Showing results (31-40 of 418) with videos related to

Sort By:
Pageof 42
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
International Journal of Cancer|July 9, 2005
Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformationBarbara Seliger, Ulrike Ritz, Soldano Ferrone
European Journal of Immunology|November 14, 2015
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitorsRosa Sottile, Pradeepa N Pangigadde, Thomas Tan, et al.
International Archives of Allergy and Immunology|January 7, 2004
Immunotherapy of malignant diseases. Challenges and strategiesEric C Ko, Xinhui Wang, Soldano Ferrone
Current Opinion in Immunology|September 3, 2004
HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?Chien-Chung Chang, Michael Campoli, Soldano Ferrone
The Keio Journal of Medicine|January 30, 2004
HLA class I defects in malignant lesions: what have we learned?Chien-Chung Chang, Michael Campoli, Soldano Ferrone
Vaccine|December 13, 2002
HLA class I antigen loss, tumor immune escape and immune selectionMichael Campoli, Chien-Chung Chang, Soldano Ferrone
Pageof 42